Updated Jul 16, 2026
Novo Holdings A/S has filed 2 SEC Form 4 filings across 2 companies in the last 90 days — buying. Lifetime open-market purchases: $10.00M.
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-05-06 | COAG | Hemab Therapeutics Holdings, Inc. | J — Other acquisition / disposition | 4.18M | — | |
| 2026-05-05 | AVLN | Avalyn Pharma Inc. | P — Open-market purchase | 555.6K | $18.00 | $10.00M |
| 2026-05-05 | AVLN | Avalyn Pharma Inc. | J — Other acquisition / disposition | 3.33M | — |
Novo Holdings A/S is a corporate insider — currently tracked as Insider of Hemab Therapeutics Holdings, Inc. (COAG). InsiderAlpha tracks every SEC Form 4 filing in real time.
2 primary Form 4 filings in the last 90 days, covering 2 companies.
Recorded transactions: 1 open-market purchases ($10.00M) and 0 open-market sales () across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Novo Holdings A/S profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.